LA
LaFrence Andrew D.C. Other
US US · SEC (Form 4)
€51,664
▲ Purchases (6 ops.)
Discover the full record of transactions filed by LaFrence Andrew D.C.. Insider active across 2 companies, notably Vyant Bio, Inc.. Cumulatively, 8 reports have been recorded. Total volume traded: €52k. The latest transaction was disclosed on 23 November 2021 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations 8 total
€8,893 5,000 shares @ €1.7786 50.0% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-032696 · 23 Nov 2021
Ideal exit: 20 Aug 2022 (T+270) €8,893 5,000 shares @ €1.7786 20.4% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-032696:0 · 23 Nov 2021
Ideal exit: 20 Aug 2022 (T+270) €8,893 5,000 shares @ €1.7786 50.0% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-029829 · 23 Nov 2021
Ideal exit: 20 Aug 2022 (T+270) €8,893 5,000 shares @ €1.7786 20.4% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-029829:0 · 23 Nov 2021
Ideal exit: 20 Aug 2022 (T+270) 29,292 shares
Common Stock, $0.0001 par value
SEC:0001493152-21-016687 · 30 Mar 2021
29,292 shares
Common Stock, $0.0001 par value
SEC:0001493152-21-016687:0 · 30 Mar 2021
€8,046 3,000 shares @ €2.6821 100.0% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-012504 · 20 May 2021
Ideal exit: 14 Feb 2022 (T+270) €8,046 3,000 shares @ €2.6821 18.4% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-012504:0 · 20 May 2021
Ideal exit: 14 Feb 2022 (T+270) About LaFrence Andrew D.C. LaFrence Andrew D.C. is a director at Vyant Bio, Inc.